MENU
GBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Generation Bio (GBIO) Earnings Date & Reports

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases... Show more

A.I. Advisor
published Earnings

GBIO is expected to report earnings to fall 82.05% to -28 cents per share on November 05

Generation Bio GBIO Stock Earnings Reports
Q3'25
Est.
$-0.28
Q2'25
Missed
by $1.28
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.04
The last earnings report on August 06 showed earnings per share of -155 cents, missing the estimate of -27 cents. With 188.85K shares outstanding, the current market capitalization sits at 42.37M.
View a ticker or compare two or three
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GBIO showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
301 Binney Street
Phone
+1 617 655-7500
Employees
174
Web
https://www.generationbio.com